RHO and neoplasm: These results suggested that myoFib‐1 and myoFib‐2 subsets might act as CAFs and contribute to ECM deposition, which remoulds the physical environment of the tumoural niche and promotes tumour progression through integrins‐dependent fibronectin assembly and Rho signaling activation and transduction.29, 30, 31